| Ticker Symbol: | KG |
|---|---|
| Exchange: | NYSE |
| Contact Info: | 501 Fifth Street Bristol TN 37620 423 989-8000 |
| CEO/President: | Brian A. Markison |
| Industry: | Medical - Drugs / Standard Industry Code: 2834 |
| Description: | King Pharmaceuticals, Inc. is a vertically integrated pharmaceutical company that manufactures, markets and sells primarily branded prescription pharmaceutical products. Through a national sales force they market their branded pharmaceutical products to general/family practitioners, internal medicine physicians, cardiologists, endocrinologists, pediatricians and hospitals across the country. |
| Shares Outstanding: | 246,620 (000) | Market Value: | 2,854,350 ($000) |
|---|---|---|---|
| Percentage of Inst.Shareholders: | 95.95% | Number of Inst.Shareholders: | 1.10% |
| Last Quarter Sales: | 396.85 ($Mil.) | Last Quarter Net Income: | 43.02 ($Mil.) |
| Last Quarter EPS: | 0.30 | P/E Ratio: | 7 |
| Most Recent Earnings: | 0.30 on 08/07/08 | Earnings Per Share: | 0.55 |
| Most Recent Split: | 4-3 on 07/20/01 | Annual Dividend Rate: | 0 |
| Most Recent Dividend: | Annual Dividend Yield: | 0% |


| PFIZER INC | -19.50 | 18.51 | |
| MERCK CO INC | -32.20 | 34.30 | |
| JOHNSON AND JOH | +18.40 | 70.67 | |
| SCHERING PLOUGH | -28.80 | 19.26 | |
| BRISTOL MYERS S | -18.00 | 21.49 |
